DMC Biotechnologies produces bio-based chemicals using fermentation.
DMC Biotechnologies has raised $39.0M in total funding. The most recent round was Series B. The last funding was announced in December 2021.
DMC Biotechnologies's investors include National Science Foundation, Capricorn Partners, Breakthrough Energy Ventures, Sofinnova Partners, Boulder Ventures.
DMC Biotechnologies is headquartered in Boulder, United States.
DMC Biotechnologies produces bio-based chemicals using fermentation.
DMC Biotechnologies is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"DMC Biotechnologies — Funding & Investors." VCBacked, December 2, 2021, https://www.vcbacked.co/company/dmc-biotechnologies. Accessed July 21, 2026.
VCBacked. (2021). DMC Biotechnologies — Funding & Investors. Retrieved July 21, 2026, from https://www.vcbacked.co/company/dmc-biotechnologies
{{cite web |title=DMC Biotechnologies — Funding & Investors |url=https://www.vcbacked.co/company/dmc-biotechnologies |website=VCBacked |access-date=July 21, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated